Products

Bupleuri Radix Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions

    • Product Name: Bupleuri Radix Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions
    • Alias: bupleuri-radix-veterinary-grade-api-for-tablets-injections-capsules-powders-granules-premix-solutions
    • Einecs: 277-046-1
    • Mininmum Order: 1 g
    • Factroy Site: Yudu County, Ganzhou, Jiangxi, China
    • Price Inquiry: admin@ascent-chem.com
    • Manufacturer: Ascent Petrochem Holdings Co., Limited
    • CONTACT NOW
    Specifications

    HS Code

    513498

    Product Name Bupleuri Radix Veterinary Grade API
    Synonym Chai Hu
    Source Root of Bupleurum chinense or Bupleurum scorzonerifolium
    Primary Use Veterinary medicinal raw material
    Dosage Forms Tablets, Injections, Capsules, Powders, Granules, Premix, Solutions
    Active Components Saikosaponins
    Appearance Light brown powder
    Solubility Slightly soluble in water
    Storage Conditions Store in a cool, dry place, protected from light
    Certificate GMP compliant
    Intended Species Livestock and poultry
    Main Functions Liver protection, anti-inflammatory, immunomodulatory
    Purity Standardized to meet veterinary pharmaceutical requirements
    Shelf Life 24-36 months
    Packaging Sealed bags or containers, various sizes available

    As an accredited Bupleuri Radix Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing Bupleuri Radix Veterinary Grade API, 1 kg foil bag, vacuum-sealed, labeled for Tablets/Injections/Capsules/Powders/Granules/Premix/Solutions use.
    Shipping Bupleuri Radix Veterinary Grade API is securely packaged in fiber drums or sealed aluminum foil bags, typically 25 kg per drum, with inner double polyethylene bags for moisture protection. Shipped via air or sea freight, it is labeled per international regulations and delivered with complete documentation to ensure quality and safety during transit.
    Storage Bupleuri Radix Veterinary Grade API should be stored in a tightly sealed, light-resistant container. Keep in a cool, dry, and well-ventilated area, away from moisture, heat sources, and direct sunlight. Store at controlled room temperature, typically between 15-25°C (59-77°F). Ensure materials are clearly labeled and protected from contamination. Avoid exposure to incompatible substances and follow relevant regulatory guidelines.
    Application of Bupleuri Radix Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions

    Applications of Bupleuri Radix Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions in Industrial Manufacturing

    As a direct manufacturer specializing in veterinary active pharmaceutical ingredients, we supply Bupleuri Radix API that serves a targeted range of real-world downstream segments. All applications listed below align with technical, regulatory, and production realities, reflecting only sectors where Bupleuri Radix is established in commercial veterinary use. Details provided cover compliance, formulation ranges, integration in production, and resulting end products, addressing the depth required by stakeholders in industrial-scale animal health formulations.

    1. Veterinary Oral Tablets Production

    Veterinary pharmaceutical manufacturers utilize Bupleuri Radix API within oral tablet formulations intended for domestic livestock, companion animals, and poultry. In this segment, the raw material contributes to proprietary multi-herbal or mono-herbal premixes, processed through direct compression or wet granulation, depending on animal species, required dosage uniformity, and bioavailability targets. The API is sieved, blended with excipients, and incorporated at precise stages prior to tablet pressing, with formulation ratios determined by species-specific dosing guidelines, functional claims, and regionally allowed actives. All procedures support batch traceability and finished product consistency to meet regulatory submission demands in animal health markets.

    Industry compliance standards

    • Veterinary Medicines Directorate (VMD, UK) feed additive and veterinary product guidelines
    • Chinese Veterinary Pharmacopoeia, latest edition (CVP)
    • GMP for Veterinary Drugs (China, EU, and US FDA cGMP)
    • Product registration dossiers: clinical trial reporting and finished product stability tests

    Typical usage ratio

    • 0.1–2.5% w/w in tablet blend, adjusted according to animal weight class, therapeutic intent, and national regulatory limits; higher inclusion for cattle/bovine applications, lower for poultry/small companion animals

    Downstream process integration

    • API dispensed during blending phase following raw material identification and QC release
    • Conforms with direct compression or blends into granulation for moisture-sensitive actives
    • Uniformity tests check even API distribution before proceeding to compression
    • Follows up with in-process control for hardness/disintegration prior to enteric coating or packaging stages

    Final product types

    • Chewable veterinary tablets for pet clinics
    • Boluses for ruminant oral administration in agriculture
    • Multi-herbal oral health support tablets for livestock
    • Poultry disease management pressed tablets

    2. Injectable Solution Manufacturing for Livestock

    Bupleuri Radix API enters the sterile injectable drug segment as an ingredient in aqueous or oily veterinary solutions designed for subcutaneous or intramuscular administration in cattle, swine, and sheep. The raw material is solubilized using validated extraction and filtration steps prior to blending with buffers, stabilizers, and isotonic agents. Sterilization is typically achieved through membrane filtration or terminal autoclave sterilization, ensuring regulatory compliance and animal safety. Each batch must comply with pharmacopeial purity standards and undergo post-sterilization potency verification to secure veterinary drug approval in global markets.

    Industry compliance standards

    • Good Manufacturing Practices for Sterile Veterinary Drugs (cGMP: FDA 21 CFR Parts 210/211 & EudraLex Volume 4)
    • Chinese Veterinary Pharmacopoeia/European Pharmacopoeia for injection quality and sterility
    • APVMA (Australia) Prescription Animal Remedy (PAR) guidelines
    • Sterility and endotoxin specification by USP <797>

    Typical usage ratio

    • 0.05–1.0% w/v in finished injectable solution, formula calibrated to animal species, local regulatory upper limits, and desired dosing regimen

    Downstream process integration

    • Introduction of Bupleuri Radix API post-QC clearance during solution compounding
    • Heat or vacuum filtration occurs prior to aseptic filling
    • pH and endotoxin levels checked in intermediate bulk solution
    • Filling into vials or ampoules precedes automated batch sterilization and in-process membrane integrity testing

    Final product types

    • Sterile single or multi-dose injectable vials for large animal practice
    • Combination veterinary parenteral preparations for inflammation management
    • Livestock immune-modulator solution ampoules

    3. Veterinary Capsule Formulation

    Veterinary capsule manufacturers incorporate Bupleuri Radix API as a primary or secondary active within gelatin or hydroxypropyl methylcellulose (HPMC) capsules produced for large-scale pharmacy supply, particularly in multi-constituent blends for gastrointestinal or hepatic applications in animals. The API enters downstream blending in dry-milled form, mixed with carriers and excipients under controlled humidity to prevent lumping. Fillers, flow agents, and disintegrants are added based on targeted capsule weight and dissolution profiles. Encapsulation machinery then fills and seals the capsules, enabling uniform dose delivery essential for prescription-only or over-the-counter veterinary products.

    Industry compliance standards

    • CVP (Chinese Veterinary Pharmacopoeia) guidelines for veterinary capsules
    • ICH Q7: GMP for Active Pharmaceutical Ingredients
    • European Feed Additives and Premixtures Quality System (FAMI-QS) for applicable livestock feed capsules
    • Certificate of suitability (CEP, EDQM) for pharmaceutical applications

    Typical usage ratio

    • 0.2–3.0% w/w of total capsule fill, calibrated for species-specific dosing ranges, monograph limits, and co-formulant interactions

    Downstream process integration

    • Bupleuri Radix powder dispensed after pre-milling/size reduction and released by in-house QC
    • Uniform blending with direct capsule fillers in conical or drum mixers
    • Encapsulation step monitored for fill weight and segregation
    • Finished capsules undergo dissolution, weight variation, and microbial load testing before plastic/aluminum blister packaging

    Final product types

    • Prescription animal capsules for liver support
    • Companion animal multi-herbal digestive care products
    • Over-the-counter pet nutritional supplements in capsule dosage

    4. Herbal Premix Integration for Feed Manufacturing

    Bupleuri Radix API is widely adopted by commercial feed mills and veterinary premix plants, where it is blended into concentrated premix powder formulations prior to incorporation into complete feed for swine, cattle, or poultry. Plants employ precise batching systems to achieve consistent API dispersion throughout the premix matrix, ensuring compliance with approved additive levels and supporting health claims in finished feeds. Quality teams monitor cross-contamination risk and homogeneity during downstream integration, with micro-dosing equipment deployed for high-value actives or multi-constituent blends targeting animal performance, growth, or immunity support in high-throughput production.

    Industry compliance standards

    • Feed Additives Directive 70/524/EEC (EU) and EC 1831/2003 on feed additive use
    • Chinese Feed Additive Approval System (Ministry of Agriculture & Rural Affairs of China)
    • ISO 22000 certified Food/Feed Safety Management System
    • FSMA (US) animal food current good manufacturing practice standards

    Typical usage ratio

    • 0.05–0.5% w/w in herbal premix powder, with specific levels defined by national feed additive regulation and intended duration of feed program

    Downstream process integration

    • Bupleuri Radix API dosed into large-scale batch mixers with carriers (e.g., soybean meal or corn starch)
    • Pneumatic conveyance ensures even distribution prior to secondary mixing
    • Homogeneity validated by in-line near-infrared (NIR) spectroscopy or extracted sample testing
    • Premix then incorporated into complete feed pellets or crumbles during main feed manufacturing

    Final product types

    • Herbal feed additive concentrates for swine and cattle
    • Premix packets for intensive broiler feeding programs
    • Complete medicated feeds for animal husbandry integrators

    5. Veterinary Water-Soluble Powder and Solution Formulations

    Bupleuri Radix API is selected by animal health companies producing water-soluble preparations and oral solutions administered via livestock drinking water systems or dosed directly to individual animals. Powder or liquid formulations require that the API be micronized and stabilized with solubilizers or flow agents to achieve rapid dispersion, enabling on-farm application and controlled dosing during health management programs. Manufacturers monitor dissolution behavior and validate shelf-life for field-ready formats, using small-batch dry blending or fully automated liquid blending and filling lines to meet veterinary standards for microbial safety and batch reproducibility.

    Industry compliance standards

    • Chinese Veterinary Pharmacopoeia for water-soluble veterinary drugs
    • GMP for Veterinary Medicine (China/EU/US FDA regulated)
    • Feed Additives Register—Veterinary Premixes and Water Soluble Products (EU Regulation 2019/4)
    • Final product inspection under ISO 9001:2015 certified systems

    Typical usage ratio

    • 0.025–0.8% w/w in powder; 0.02–0.3% w/v in solution, tailored by water volume per head, animal age, and regulatory dosing constraint for continuous or pulse dosing protocols

    Downstream process integration

    • API micronized and pre-screened for solubility/dispersibility
    • Introduced into ribbon blenders or solution tanks before bulking/addition of flavoring agents
    • Powder packaged into sachets; solutions filled aseptically into plastic bottles or pouches
    • Microbial testing and rapid-disperse time measurement finalized before storage/distribution

    Final product types

    • Livestock water-soluble powder sachets for drinking water dosing
    • Oral veterinary health solutions for pigs and poultry
    • Soluble powders for multi-herb supplementation in commercial farming systems

    Free Quote

    Competitive Bupleuri Radix Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please contact us at +8615365186327 or mail to admin@ascent-chem.com.

    We will respond to you as soon as possible.

    Tel: +8615365186327

    Email: admin@ascent-chem.com

    Get Free Quote of Ascent Petrochem Holdings Co., Limited

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    Bupleuri Radix Veterinary Grade API: Turning Herbal Tradition into Practical Solutions

    Introduction to Bupleuri Radix API for Veterinary Use

    Our team has spent years working with medicinal herbs, learning not just how plants grow, but how their subtle qualities can serve animal health. Bupleuri Radix, known in TCM as Chai Hu, delivers one of those rare synergies between tradition and practical utility. In the veterinary field, most effective long-term interventions rely on truly understanding what the raw plant delivers and how the active constituents can be reliably presented in modern pharmaceutical forms.

    We manufacture Bupleuri Radix into a highly purified Active Pharmaceutical Ingredient (API), carefully controlled to meet stringent veterinary standards. We refine the extract, check each batch's active marker levels, and keep the physical qualities consistent so formulators and veterinarians get predictable results, whether for tablets, capsules, injections, granules, powders, premixes, or solutions. This isn't just about providing an ingredient. It's about joining the long story of animal care with precise industrial practice and updated analytical knowledge.

    Origins and Key Characteristics of Veterinary Grade Bupleuri Radix API

    Veterinary treatments face many of the same challenges as human medicine: the need for safety, predictability, and measurable results. Our Bupleuri Radix API comes from cultivated plants grown under monitored conditions, avoiding wild-harvested variability and ensuring lot-to-lot similarity. Our extraction focuses on the main bioactive constituents—primarily saikosaponins—since these support the immune-modulating, hepatoprotective, and anti-inflammatory actions veterinarians value.

    Each batch passes through a controlled process: careful raw material selection, low-temperature extraction, advanced filtration, and concentrated preparation. This attention to the details makes the difference between a raw powder and a true veterinary pharmaceutical-grade API. The model and physical form we provide suits multiple delivery modes. Veterinarians and formulators will find it available as a fine, consistent powder for direct tableting or capsule filling, as a water-dispersible granule for instant proportioning, and in stabilised solution form for injectable or liquid dosing. Each presentation is intended for practical workflow in veterinary production or compounding labs—less waste, easier portioning, and simplified blending with other actives or excipients.

    What Sets Our Bupleuri Radix Apart?

    The most common challenge in producing plant-based APIs is the ever-fluctuating quality of raw materials. Heavy metal content, unexpected plant bacteria, and inconsistent active compound levels constantly threaten reproducibility. Our process keeps a strict fingerprint on all major and minor constituents by deploying HPLC and TLC analysis from the leaf stage through to the final product. We specifically select for high saikosaponin A, C, and D content, which animal studies link to immune and liver function support.

    Many competitors push undistinguished herbal powders, cut with root bark or unregulated fillers. In our lab, we reject shipments with any sign of adulteration or excessive bio-burden. Our process never includes artificial dyes, preservatives, synthetic flavorings, or undisclosed carriers. The product ships in food-grade, humidity-controlled vacuum pouches, maintaining stability even in hot, humid climates. This matters not only for compliance, but because it helps prevention of mold and end-of-shelf-life degradation seen with less-refined herbal APIs.

    Standardisation brings even more practical benefits. It makes breeding and feeding trials in preclinical settings less chaotic. Our Bupleuri Radix API works in products for livestock, companion animals, and exotics, where treating subclinical inflammation, supporting liver metabolism during intensive feeding, or helping animals transition through environmental stress can make or break farm economics.

    Bupleuri Radix in Formulated Veterinary Products

    We designed this API for inclusion by integrators and contract manufacturers into a suite of delivery systems. Tablet and capsule makers will find the powder flows predictably and compresses evenly when matched with microcrystalline cellulose or starches. For feed premixes, our granulated form blends without dust and resists clumping under warehouse conditions. Injection product developers use our stabilised solution, which is highly clarified and sterile-filtered. Powders disperse without surprising sediment or undissolved particles if users follow recommended techniques.

    Our customers—mixers, veterinarians, and supplement houses—commonly report little variation from batch to batch because we match all active marker specifications and microbial limits with every lot. This steadiness, rarely matched by less precise pellet or crude root products, means dose accuracy, less spoilage, and fewer troubleshooting headaches on the production floor.

    Addressing Common Bupleuri Radix Issues and Misconceptions

    Many industry newcomers expect all Bupleuri Radix powder to produce the same effects or physical results. This isn't usually the case. We have encountered multiple buyers who previously struggled with batches sourced from unknown origins, resulting in odd smells, color changes, or even accidental overdoses due to mislabelled concentration. Our standard-grade API supports both low-dose chronic supplement formulas for immune modulation and short-term high-dose protocols during acute hepatic episodes.

    Another concern is compatibility: Some supplement makers blend Bupleuri Radix with other botanicals or vitamins but run into gelling, settling, or separation problems in the final product. Our team has addressed these issues repeatedly, experimenting with temperature management, granulation sizes, and solution pH to facilitate cleaner processing and improved shelf-life. Customers working in solution or injectable systems notice that our clarified standard preserves natural color and aroma, without offensive flavors or the instability that comes from a less-refined raw powder.

    Dose control often comes up as a technical hurdle, especially when working with high-potency batches. By analytically measuring each batch’s active saikosaponin profile, we can make solid recommendations tailored to the absorption profiles of dogs, cats, pigs, horses, cattle, or less common species. One-size-fits-all dosing doesn't work; real-world efficacy hinges on this chemical consistency.

    Regulatory and Quality Standards in Veterinary API Manufacturing

    Animal health keeps rising on the regulatory agenda. Markets worldwide enforce minimum standards for plant-based APIs, such as limits on pesticides, heavy metals, or residual solvents. We keep test results for each lot to guarantee compliance with carrier country requirements such as China, the European Union, or North America. We regularly certify our production through independent labs as well as internal QA, and we maintain full granularity of test records, including retention samples of every production run.

    Quality for herbal actives means more than just cleanliness. A real veterinary-grade ingredient shows almost no batch-to-batch variation across metrics ranging from color and flow to analytical HPLC fingerprint. Our equipment-maintained separation, synthetic filtration, and low-temperature concentration—paired with a commitment to hands-on routine inspection—make sure the finished API stays within narrow physical and chemical limits. No off-spec lots ever reach customer shelves; rejections go for forensic review, not market salvage. This transparency proves invaluable for both local clinics and multinational firms seeking market authorisation.

    Field Realities: Veterinary Deficiencies Without Reliable Bupleuri Radix API

    Years ago, before robust APIs reached the international scene, many veterinarians and nutritionists relied on fresh or air-dried Bupleuri Radix root, hand-shredded or home-pulverised. These preparations produced differing results. Subtherapeutic doses, contamination, or interactions with unknown substances often made quality control impossible. Adoption of our standardised API ended guesswork and accidental overdosing.

    In one example from a poultry nutritionist, commercial clients saw reduced feather-picking, improved weighed gain, and shorter withdrawal times due to consistent inclusion of our API in farm-scale premixes. Dairy farm operators seeking hepatoprotective support for high-yielding cows switched from a crude decoction to our free-flowing granule; the result was steadier milk output under environmental heat stress. Similar gains appear in companion animal lines, where clear, odor-controlled powder integrates well into chewable tablets, attracting less taste rejection from animals.

    Dogs and cats undergoing medication cycles for hepatic distress often develop sensitivities to synthetic adjuvants or fillers. Formulators working with our clarified solution and powder report that animals tolerate the plant-based ingredient better, with improved palatability and reduced GI upsets. There are clear downstream benefits: less medicine wastage, improved compliance, and fewer callbacks from clients whose pets refuse bitter or poorly soluble medications.

    Practical Realities of Tableting, Encapsulation, and Mixing with Our Bupleuri Radix API

    Pharmaceutical processing presents an array of obstacles for plant extract powders: uneven density, tendency to clump under humid conditions, and unpredictable hydration rates that change tableting or capsule quality. We've countered these hurdles by refining both particle size and moisture content. Each lot's bulk density and moisture are tested and logged. The result? No sticky clumps, and flowing characteristics that make automation—rollet presses, capsule rotaries, or ribbon blenders—consistently efficient.

    Feed premix producers need bulk formats and steady flow. Our powder handles pneumatic and gravity-fed loaders without dust storms or settle-out in long warehouse storage. Small producers, such as veterinary clinics compounding custom doses for chronic use, benefit from the fine dispersibility and the neutral, slightly herbal aroma that doesn't overpower the target formulation.

    For injectable project developers, we offer a clarified, pH-balanced concentrate, free from plant debris or crude mucilage that can risk clogging needles or injecting unwanted particulates. It dilutes with saline or suitable carriers, preserving both solubility and shelf stability without the browning or settling problems typical of loosely filtered extracts.

    Animal Safety and User Considerations

    Our direct clinical partners and field trials supply important safety feedback. Microbial control begins at the farm, avoiding waterlogged crops or field contamination. Every shipment is analyzed for salmonella, E. coli, fungal spores, pesticide residues, and heavy metals like arsenic or lead. Beyond compliance, we scrutinize interactions with typical formulation adjuncts—probiotics, vitamins, mineral mixes. Unwanted side effects, like GI discomfort or chemical incompatibility, get flagged during scaled-up blending trials and pilot production.

    For veterinary clients dealing with small mammals, birds, or reptiles—species with exceptional sensitivity to herbal actives—our analytics-driven recommendations keep dose levels within established safety limits. Should new animal data emerge, we feed that directly back into the next season's batch profile and adjust our manufacture. By listening to both veterinary specialists and animal caretakers, we improve our product each year.

    On the end user side, palatability matters. Owners and veterinarians report that animals receiving our product in tablets or granules show less avoidance, less spitting, and lower handling stress. Physiological tolerance stays high when the extract is clean and precisely standardised, compared to broader-spectrum, raw root powder imports.

    The Market Landscape and Bupleuri Radix’s Role

    As animal agriculture advances, veterinarians and feed formulators look for effective alternatives and adjuncts to mainstream pharmaceuticals. On many farms, hormonal drugs and corticosteroids lose ground to plant-based immunomodulators, and Bupleuri Radix is right in the center of that shift. Its particular utility comes in stress management—whether from environmental pressures, high-density livestock operations, or immunity challenges during growth and transition.

    We see our API’s practical impact every time a feedlot operator, aquaculture technician, or pet supplement house upgrades from crude root powder to controlled pharmaceutical grade. Reporting fewer product recalls, less batch rejection by quality inspectors, and reduced animal handling stress, these customers build reliability and trust with end-users: farmers, pet owners, and veterinarians who demand more than inconsistent herbal folklore.

    Industry Challenges and Ongoing Solutions

    Every year, raw herbal input costs rise, and counterfeiting persists, mostly in root powder markets. We maintain tight grower contracts and direct oversight of planting, harvesting, and processing. Our chemical fingerprinting provides irrefutable proof of product origin and purity, allowing us to fend off substandard or adulterated imports. The veterinary sector, demanding the same precision as human medicine, deserves no less.

    Technical hurdles never stop. Moisture management, powder caking, bulk handling logistics, and maintaining full-spectrum actives through the drying and extraction process—these require continuous innovation. Our team invests in equipment upgrades every season, not just to keep up, but to raise standards. We frequently run cross-comparison studies of our own output against industry samples, and publish the results in open forums. That active transparency keeps us honest and encourages the field to move forward.

    Looking Ahead: Bupleuri Radix in the Future of Veterinary Medicine

    Market demand shapes our research agenda. Clients ask for tailored solutions—higher or lower potency, specific batch forms, or alternative solvent systems. Our lab team works on each new request, matching customer needs without compromising the no-additive, no-filler promise. As regulatory authorities continue to push for increased traceability, record-keeping, and evidence of efficacy, our API’s tight standardisation paves the way for next-generation veterinary nutraceuticals and prescription actives.

    The future, as we see it, involves closer integration between plant-based APIs and evidence-centered veterinary practice. That means large-scale feeding trials, peer-reviewed publications, and closer interaction with practitioners, not anonymous bulk commodity sales. Our long-term partners already build new product lines on that confidence, introducing real consistency to a sector famous for irregular quality.

    Summary: Our Enduring Commitment to Veterinary Science

    This Bupleuri Radix Veterinary Grade API represents far more than an herbal extract; it brings together old knowledge and precise, modern technology. Our factory’s focus on chemical consistency, batch reproducibility, and field efficacy responds to the real-world problems veterinarians and animal health professionals face every day. Years of handling raw roots, troubleshooting bottling lines, and consulting with clinics convinced us that the veterinary sector benefits most from transparency, evidence, and hands-on stewardship.

    We manufacture every lot not just for sale but as a promise to the client and the animals in their care. Whether as tablets, powders, granules, solutions, or premix, our process links the wisdom of herbal tradition with the uncompromising standards of industrial pharmaceutical production. As veterinarians, formulators, and clients demand more from their plant-based APIs, we’re determined to meet and exceed those expectations—batch after batch, year after year.

    Top